Aptevo Therapeutics Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Stromatt Scott C | Chief Medical Officer and SVP | Option Exercise | 27,381 | — | — | 174,576 | Feb 3, 2018 |
| Maddux Randy Joe | Senior VP, Operations | Purchase | 25,000 | $2.76 | $69,000 | 25,000 | Nov 15, 2017 |
| Gross Jane A | See Remarks | Tax Withholding | 10,076 | $1.83 | $18,439 | 68,433 | Aug 1, 2017 |
| Stromatt Scott C | Chief Medical Officer and SVP | Option Exercise | 78,123 | — | — | 147,195 | Aug 1, 2017 |
| White Marvin L | President and CEO | Option Exercise | 17,828 | — | — | 66,332 | May 22, 2017 |
| Stromatt Scott C | Chief Medical Officer and SVP | Tax Withholding | 6,570 | $1.78 | $11,695 | 69,072 | Mar 10, 2017 |
| Lamothe Jeffrey G. | SVP, CFO and Treasurer | Option Exercise | 18,863 | — | — | 46,274 | Mar 10, 2017 |
| Gross Jane A | See Remarks | Tax Withholding | 3,837 | $1.78 | $6,830 | 40,416 | Mar 1, 2017 |
| Gross Jane A | See Remarks | Option Exercise | 18,135 | — | — | 21,793 | Feb 3, 2017 |
| Lamothe Jeffrey G. | SVP, CFO and Treasurer | Option Exercise | 25,340 | — | — | 25,340 | Feb 3, 2017 |
| Stromatt Scott C | Chief Medical Officer and SVP | Option Exercise | 27,381 | — | — | 29,625 | Feb 3, 2017 |
| Emergent BioSolutions Inc. | — | Other | 20,229,074 | — | — | 20,230,074 | Aug 1, 2016 |
| Emergent BioSolutions Inc. | — | Other | 20,229,849 | — | — | — | Jul 29, 2016 |